DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Bethesda North Marriott Hotel and Conference Center

2018 年 02 月 05 日 7:00 上午 - 2018 年 02 月 07 日 3:00 下午

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

Session 8 Track 4: Using Submission Management to Enable Streamlined Regulatory Planning

Session Chair(s)

Michelle L. Charles, MPH

Michelle L. Charles, MPH

Director, Regulatory Affairs, Gene Therapy Program

University of Pennsylvania, Perelman School of Medicine, United States

This session will focus on how you can work business efficiency and project management into all aspects of regulatory submissions. We will begin with a presentation focused on the implementation of a global submission planning tool to enable portfolio management, then move to a presentation optimizing submission resources, and end with how to efficiently manage a submission lifecycle.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe the benefits of an integrated approach to regulatory submission authorization, planning, and execution
  • Recognize the value of using unified global submission planning process and tools to develop portfolio-level reporting and information to drive strategic decision-making for prioritization, resource management, and to drive planning for manufacturing and sales and marketing divisions

Speaker(s)

Laura  Shelley, RPh, PMP

Enabling Global Regulatory Submission Project and Portfolio Management Via a Unified Submission Planning Toolset

Laura Shelley, RPh, PMP

Merck & Co., Inc, United States

Director

Laurie  Henricks

Submission Lifecycle Management

Laurie Henricks

Arena Pharmaceuticals, Inc., United States

Sr Director, Regulatory Operations

Stephanie J Hughes

Utilizing Submissions Management to Free Up Resources in Regulatory Affairs

Stephanie J Hughes

Teva Pharmaceuticals Inc., United States

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。